Skip to content

A program of International Vaccine Access Center by Johns Hopkins Bloomberg School of Public Health

Value of Immunization Compendium of Evidence

Home
Evidence Briefs
Knowledge Hub
Advocacy
Vaccine Resources
About VoICE

The impact of the U.S. maternal Tdap vaccination program on preventing pertussis in infants <2 months of age: a case-control evaluation

Post navigation

← Cost-effectiveness of analysis of pertussis vaccination during pregnancy in Japan

The effectiveness of maternal pertussis vaccination in protecting newborn infants in Brazil: a case-control study →

VoICE is a project of the International Vaccine Access Center (IVAC) at the Johns Hopkins Bloomberg School of Public Health, and is made possible with support from the Bill & Melinda Gates Foundation. We thank the many partners who have contributed their time, energy and expertise to VoICE.

Learn More About IVAC
Contact Us

© 2024 The International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health. All rights reserved

Translation Disclaimer